Exact Mass: 669.0655

Exact Mass Matches: 669.0655

Found 9 metabolites which its exact mass value is equals to given mass value 669.0655, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Adenophostin A

Adenophostin A

C16H26N5O18P3 (669.0486)


D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D002120 - Calcium Channel Agonists D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

Tiazofurin adenine dinucleotide

2-{5-[({[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-3,4-dihydroxyoxolan-2-yl}-1,3-thiazole-4-carboximidate

C19H25N7O14P2S (669.0655)


   

Gp-Up|GpUp|GpUp(3)|Guanyl(3-5)uridin-3-phosphat|guanylyl-(3->5)-[3]uridylic acid|O5-[3]guanylyl-[3]uridylic acid|O5-[3]Guanylyl-[3]uridylsaeure

Gp-Up|GpUp|GpUp(3)|Guanyl(3-5)uridin-3-phosphat|guanylyl-(3->5)-[3]uridylic acid|O5-[3]guanylyl-[3]uridylic acid|O5-[3]Guanylyl-[3]uridylsaeure

C19H25N7O16P2 (669.0833)


   

3,6,8-TRIS(DIMETHYLAMINOSULFONYL)-1-PYRENYL PHOSPHATE PYRIDINE SALT

3,6,8-TRIS(DIMETHYLAMINOSULFONYL)-1-PYRENYL PHOSPHATE PYRIDINE SALT

C26H28N3O10PS3 (669.0674)


   

[[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [5-(4-carbamoyl-1,3-thiazol-2-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

[[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [5-(4-carbamoyl-1,3-thiazol-2-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

C19H25N7O14P2S (669.0655)


D004791 - Enzyme Inhibitors

   

Masupirdine (mesylate)

Masupirdine (mesylate)

C23H32BrN3O9S3 (669.0484)


Masupirdine mesylate (SUVN-502 mesylate) is a potent, selective, orally bioavailable, and brain penetrant 5-HT6 receptor antagonist (Ki of 2.04 nM for human 5-HT6 receptor). Masupirdine mesylate (SUVN-502 mesylate) shows high selectivity over 5-HT2A receptor and other 100 target sites, and has potential for treatment of Alzheimer's disease[1].

   

[2-(6-aminopurin-9-yl)-4-{[3-hydroxy-6-(hydroxymethyl)-4,5-bis(phosphonooxy)oxan-2-yl]oxy}-5-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

[2-(6-aminopurin-9-yl)-4-{[3-hydroxy-6-(hydroxymethyl)-4,5-bis(phosphonooxy)oxan-2-yl]oxy}-5-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

C16H26N5O18P3 (669.0486)


   
   

[(2s,3r,4s,5r)-2-(6-aminopurin-9-yl)-4-{[(2r,3s,4r,5r,6r)-3-hydroxy-6-(hydroxymethyl)-4,5-bis(phosphonooxy)oxan-2-yl]oxy}-5-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

[(2s,3r,4s,5r)-2-(6-aminopurin-9-yl)-4-{[(2r,3s,4r,5r,6r)-3-hydroxy-6-(hydroxymethyl)-4,5-bis(phosphonooxy)oxan-2-yl]oxy}-5-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

C16H26N5O18P3 (669.0486)